Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delbruck Lifesciences is a pharmaceutical company headquartered in India, specializing in the development and distribution of generic and specialty healthcare products. The company's portfolio spans several critical therapeutic areas, including cardiology, diabetology, neurology, and gastroenterology. Delbruck aims to improve patient access to essential medicines through a robust supply chain and a focus on quality-driven manufacturing processes. Their business model encompasses both domestic trade and international exports of finished formulations. The company provides a range of oral solids and other dosage forms targeting chronic and acute conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delbruk Lifescience.